Back to top

Myriad Genetics Inc: (MYGN)

(Delayed quote from NSDQ) As of Oct 1, 2014 03:59 PM ET

 Add to portfolio

 ZacksTrade Now

$38.30 USD

38.30

-0.27 (-0.70%)

Volume: 500,764

Zacks Rank : 3-Hold [?]     3    

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1 Strong Buy 26.65%
2 Buy 18.84%
3 Hold 10.45%
4 Sell 4.76%
5 Strong Sell 2.56%
S&P 500 10.28%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The way to access to the Zacks Rank

Financial Overview

Fundamental Ratios

P/E
P/E (F1) 20.06
Trailing 12 Months 16.06
PEG Ratio 1.56
EPS Growth
vs. Previous Year -9.43%
vs. Previous Quarter -20.00%
   
Sales Growth
vs. Previous Year 8.41%
vs. Previous Quarter 3.19%
   
Price Ratios
Price/Book 4.05
Price/Cash Flow 14.30
Price / Sales 3.64
ROE
6/30/14 26.89
3/31/14 27.78
12/31/13 27.22
ROA
6/30/14 23.75
3/31/14 24.78
12/31/13 24.46
Current Ratio
6/30/14 4.00
3/31/14 4.69
12/31/13 6.74
Quick Ratio
6/30/14 3.70
3/31/14 4.42
12/31/13 6.74
Operating Margin
6/30/14 24.25
3/31/14 25.63
12/31/13 25.48
Net Margin
6/30/14 22.65
3/31/14 24.45
12/31/13 25.48
Pre-Tax Margin
6/30/14 35.71
3/31/14 38.31
12/31/13 39.94
Book Value
6/30/14 9.61
3/31/14 9.90
12/31/13 9.04
Inventory Turnover
6/30/14 10.20
3/31/14 16.78
12/31/13 31.00
Debt-to-Equity
6/30/14 0.00
3/31/14 0.00
12/31/13 0.00
Debt to Capital
6/30/14 0.00
3/31/14 0.00
12/31/13 0.00
 

MYGN Chart by YCharts